Hydrophobic polycationic coatings inactivate wild-type and zanamivir- and/or oseltamivir-resistant human and avian influenza viruses

Biotechnology Letters

Volumn 30, Issue 3, 2008, Pages 475-479

  Haldar, Jayanta ^a   Chen, Jianzhu ^a   Tumpey, Terrence M ^b   Gubareva, Larisa V ^b   Klibanov, Alexander M ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antiviral; Polyethylenimine; Quaternary amines; Relenza; Tamiflu

Indexed keywords

ANTIVIRAL DRUGS; POLYETHYLENIMINE; QUATERNARY AMINES; RELENZA; TAMIFLU;

AMINES; COATED MATERIALS; DISEASES; HYDROPHOBICITY; ORGANIC POLYMERS; POSITIVE IONS; VIRUSES;

DRUG PRODUCTS;

ANTIVIRUS AGENT; DRUG DERIVATIVE; ENZYME INHIBITOR; N,N DODECYL,METHYL POLYETHYLENIMINE; N,N-DODECYL,METHYL-POLYETHYLENIMINE; OSELTAMIVIR; POLYETHYLENEIMINE; UNCLASSIFIED DRUG; ZANAMIVIR;

ANIMAL; ANTIVIRAL RESISTANCE; ARTICLE; CELL LINE; DRUG EFFECT; HUMAN; INFLUENZA VIRUS A;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DRUG RESISTANCE, VIRAL; ENZYME INHIBITORS; HUMANS; INFLUENZA A VIRUS; OSELTAMIVIR; POLYETHYLENEIMINE; ZANAMIVIR;

AVES; AVIAN INFLUENZA VIRUS; INFLUENZA A VIRUS; INFLUENZAVIRUS A; ORTHOMYXOVIRIDAE;

EID: 38649124050     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-007-9565-5     Document Type: Article

References (22)

1. Dowdle WR (2006) Influenza pandemic periodicity, virus recycling, and the art of risk assessment. Emerg Infect Dis 12:34-39
2. Gubareva LV, Bethell R, Hart GJ, Murti KG, Penn CR, Webster RG (1996) Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-Guanidino-Neu5Ac2en. J Virol 70:1818-1827
3. Gubareva LV, Matrosovich MN, Brenner MK, Bethell RC, Webster RG (1998) Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis 178:1257-1262
4. Gubareva LV, Kaiser L, Hayden FG (2000) Influenza virus neuraminidase inhibitors. Lancet 355:827-835
5. Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG (2001) Selection of influenza virus mutations in experimentally infected volunteers treated with oseltamivir. J Infect Dis 183:523-531
6. Gubareva LV, Webster RG, Hayden FG (2002) Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res 53:47-61
7. Haldar J, An D, Álvarez de Cienfuegos L, Chen J, Klibanov AM (2006) Polymeric coatings that inactivate both influenza virus and pathogenic bacteria. Proc Natl Acad Sci USA 103:17667-17671
8. Haldar J, Weight AK, Klibanov AM (2007) Preparation, application, and testing of permanently antibacterial and antiviral coatings. Nat Protoc 2 (in press)
9. Herlocher ML, Truscon R, Elias S, Yen H-L, Roberts NA, Ohmit SE, Monto AS (2004) Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis 190:1627-1630
10. Hiti AL, Nayak DP (1982) Complete nucleotide sequence of the neuraminidase gene of human influenza virus A/WSN/33. J Virol 41:730-734
11. Jackson HC, Roberts N, Wang MZ, Belshe R (2000) Management of influenza; use of new antivirals and resistance perspective. Clin Drug Investig 20:447-454
12. Kawaoka Y, Krauss S, Webster RG (1989) Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 63:4603-4608
13. Klibanov AM (2007) Permanently microbicidal materials coatings. J Mater Chem 17:2479-2482
14. Lewis K, Klibanov AM (2005) Surpassing nature: rational design of sterile-surface materials. Trends Biotechnol 23:343-348
15. Mishin VP, Hayden FG, Gubareva LV (2005) Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother 49:4515-4520
16. Moscona A (2005) Neuraminidase inhibitors for influenza. N Engl J Med 353:1363-1373
17. Park D, Wang J, Klibanov AM (2006) One-step, painting-like coating procedures to make surfaces highly and permanently bactericidal. Biotechnol Prog 22:584-589
18. Roberts NA (2001) Treatment of influenza with neuraminidase inhibitors: virological implication. Philos Trans R Soc Lond B 356:1895-1897
19. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG (2005) Characterization of the 1918 influenza virus polymerase genes. Nature 437:889-893
20. Van Rompuy L, Jou WM, Huylebroeck D, Friers W (1982) Complete nucleotide sequence of a human influenza neuraminidase gene of subtype N2 (A/Victoria/3/75). J Mol Biol 161:1-11
21. Webster RG, Peiris M, Chen H, Guan Y (2006) H5N1 outbreaks and enzootic influenza. Emerg Infect Dis 12:3-8
22. Wright PF, Webster RG (2001) Orthomyxoviruses, fields virology. Lippincott Williams & Wilkins, Philadelphia, pp 1533-1579